Home Industry Reports Custom Research Blogs About Us Contact us

伴侣动物药物市场规模和份额、副产品(药物、疫苗、药用饲料添加剂)、动物类型(狗、猫、马等)、给药途径(口服、注射、外用、其他)、分销渠道(兽医医院) 、兽医诊所、药房和药店、电子商务)、区域预测、行业参与者、增长统计报告 2024-2032

Report ID: FBI 5397

|

Published Date: Aug-2024

|

Format : PDF, Excel

市场展望:

伴侣动物药品市场规模在 2023 年超过 143 亿美元,预计到 2032 年底将超过 262.9 亿美元,2024 年至 2032 年复合年增长率超过 7%。

Base Year Value (2023)

USD 14.3 Billion

19-23 x.x %
24-32 x.x %

CAGR (2024-2032)

7%

19-23 x.x %
24-32 x.x %

Forecast Year Value (2032)

USD 26.29 Billion

19-23 x.x %
24-32 x.x %
Companion Animal Drugs Market

Historical Data Period

2019-2023

Companion Animal Drugs Market

Largest Region

North America

Companion Animal Drugs Market

Forecast Period

2024-2032

Get more details on this report -

市场动态:

增长动力和机遇:

宠物收养率的提高,尤其是在发达地区,正在推动伴侣动物药物市场的增长。宠物日益人性化也导致对伴侣动物优质保健产品的需求增加。此外,兽医学的进步以及人们对宠物预防性医疗保健重要性的日益认识也进一步推动了市场的增长。

行业限制:

伴侣动物药物的严格监管和审批程序对市场增长构成了主要限制。这些药物的开发和生产相关的高成本也是市场参与者面临的重大挑战。此外,来自整体疗法和自然疗法等替代疗法的竞争正在影响伴侣动物药物市场的增长潜力。

区域预报:

Companion Animal Drugs Market

Largest Region

North America

37% Market Share in 2023

Get more details on this report -

北美:

北美伴侣动物药品市场主要是由美国和加拿大的高宠物拥有率推动的。对宠物健康的日益关注以及对宠物预防保健的需求不断增长是促进该地区市场增长的关键因素。

亚太地区:

在亚太地区,中国、日本和韩国等国家的伴侣动物药物市场正在快速增长。这些国家可支配收入的增加,加上人们对宠物作为家庭成员的看法不断变化,正在推动对伴侣动物药物和保健产品的需求。

欧洲:

在欧洲,英国、德国和法国是伴侣动物药物的主要市场。人们对宠物健康的认识不断增强,宠物人性化趋势不断增强,正在推动这些国家的市场增长。兽医的进步和各种伴侣动物药物的供应也有助于欧洲市场的扩张。

Report Coverage & Deliverables

Historical Statistics Growth Forecasts Latest Trends & Innovations Market Segmentation Regional Opportunities Competitive Landscape
Companion Animal Drugs Market
Companion Animal Drugs Market

细分分析:

""

在细分方面,根据产品、动物类型、给药途径、分销渠道对全球伴侣动物药物市场进行分析。

伴侣动物药物市场:

产品:

伴侣动物药物市场可细分为药物、疫苗和药用饲料添加剂。由于针对不同动物健康状况的药物种类繁多,预计药物市场将主导该领域。

动物类型:

市场按动物类型进一步细分,包括狗、猫、马等。由于人们越来越多地采用狗和猫作为宠物,并且人们对其医疗保健需求的认识不断增强,预计狗和猫将占据重要的市场份额。

给药途径:

市场还可以按给药途径进行细分,包括口服、注射、外用等。由于易于给药和患者依从性,预计口服给药是最优选的途径。

分销渠道:

伴侣动物药品市场可按分销渠道细分,包括兽医医院、兽医诊所、药房和药店以及电子商务。由于拥有兽医专业人员来开处方和管理药物,兽医医院和诊所预计将主导市场。

Get more details on this report -

竞争格局:

伴侣动物药物市场的竞争格局的特点是大型制药公司和专门从事动物保健的小型生物技术公司混合在一起。主要参与者越来越注重研发,推出针对宠物常见疾病(如肥胖、关节炎和传染病)的创新产品。市场动态受到战略合作、兼并和收购的影响,这些战略合作、兼并和收购增强了产品组合和市场覆盖范围。此外,人们对宠物保健和兽医服务意识的不断提高,加上宠物人性化趋势的不断增长,导致对伴侣动物治疗的投资增加。遵守法规和维持高质量标准对于公司在这个竞争环境中取得成功至关重要。

顶级市场参与者

-硕腾

- 默克动物保健

- Elanco 动物保健

- 拜耳动物保健

- 勃林格殷格翰

- 维托喹诺

- Ceva Santé Animale

- 德克拉制药公司

- IDEXX 实验室

- 雀巢普瑞纳宠物护理公司

Our Clients

Why Choose Us

Specialized Expertise: Our team comprises industry experts with a deep understanding of your market segment. We bring specialized knowledge and experience that ensures our research and consulting services are tailored to your unique needs.

Customized Solutions: We understand that every client is different. That's why we offer customized research and consulting solutions designed specifically to address your challenges and capitalize on opportunities within your industry.

Proven Results: With a track record of successful projects and satisfied clients, we have demonstrated our ability to deliver tangible results. Our case studies and testimonials speak to our effectiveness in helping clients achieve their goals.

Cutting-Edge Methodologies: We leverage the latest methodologies and technologies to gather insights and drive informed decision-making. Our innovative approach ensures that you stay ahead of the curve and gain a competitive edge in your market.

Client-Centric Approach: Your satisfaction is our top priority. We prioritize open communication, responsiveness, and transparency to ensure that we not only meet but exceed your expectations at every stage of the engagement.

Continuous Innovation: We are committed to continuous improvement and staying at the forefront of our industry. Through ongoing learning, professional development, and investment in new technologies, we ensure that our services are always evolving to meet your evolving needs.

Value for Money: Our competitive pricing and flexible engagement models ensure that you get maximum value for your investment. We are committed to delivering high-quality results that help you achieve a strong return on your investment.

Select Licence Type

Single User

US$ 4250

Multi User

US$ 5050

Corporate User

US$ 6150

伴侣动物药物市场规模和份额、副产...

RD Code : 24